UnitedHealth Group saw its price target slashed from $640 to $510 by Robert W. Baird, despite maintaining an “outperform” ...

Amazon has responded to tariff concerns by leaning on its third-party sellers, who bulked up inventory to maintain pricing ...

Tesla’s European joyride is skidding hard in April, with sales nose-diving across key markets like Sweden, Denmark, and ...

AMD is preparing to report its Q1 2025 earnings with strong expectations: $0.94 EPS and $7.12 billion in revenue. Analyst Jay ...

California State Teachers Retirement System reduced its Exxon Mobil holdings by 9.1% in Q4, selling 532,382 shares, yet it ...

The Manufacturers Life Insurance Company reduced its Home Depot holdings by 4.7% in Q4, selling 38,498 shares. This left the ...

Alphabet, despite a tech giant glow-up, has underperformed the broader market, dropping 16.1% year-to-date while others ...

Nebula Research & Development LLC more than doubled its Chevron holdings in Q4, snapping up 5,165 additional shares worth ...

Microsoft jolted Wall Street with a powerful 7.63% stock surge, closing at $425.40 on May 1st, and even inched up after-hours ...

Eli Lilly’s Q1 earnings smashed expectations, fueled by surging demand for its blockbuster drugs Zepbound and Mounjaro. The ...

JPMorgan Chase strutted into Q1 2025 with a financial performance that deserves a standing ovation and maybe a bonus or two.

Analysts at Cantor Fitzgerald shaved a whopping two cents off their FY2025 EPS forecast for AbbVie, from $12.33 to $12.31, ...